BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency [Reuters]
BiondVax Pharmaceuticals Ltd. - American Depositary Shares (BVXV)
US:NASDAQ Investor Relations:
biondvax.com/investors
Company Research
Source: Reuters
BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency | Reuters Reuters Staff 1 Min Read Dec 27 (Reuters) - Biondvax Pharmaceuticals Ltd: * BIONDVAX PLANS PHASE 3 CLINICAL TRIAL FOLLOWING RECEIPT OF SCIENTIFIC ADVICE FROM THE EUROPEAN MEDICINES AGENCY (EMA) * BIONDVAX PHARMACEUTICALS - M-001? PHASE 3 TRIAL EXPECTED TO TAKE PLACE IN EASTERN EUROPE & BEGIN PRIOR TO 2018/19 FLU SEASON * BIONDVAX-?EMA‘S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) ADVICE TO FACILITATE PROCEDURES IN COUNTRIES WHERE PHASE 3 STUDY WILL TAKE PLACE? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Biondvax Plans Phase 3 Clinical Trial Following Receipt Of Scientific Advice From The European Medicines Agency Dec 27 (Reuters) - Biondvax Pharmaceuticals Ltd: * BIONDVAX PLANS PHASE 3 CLINICAL TR
Show less
Read more
Impact Snapshot
Event Time:
BVXV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVXV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVXV alerts
High impacting BiondVax Pharmaceuticals Ltd. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics